Navigation Links
New Jersey Health Foundation President Addresses Panel at AAHC Research Efficiency Conference
Date:1/8/2014

NEW BRUNSWICK, N.J., Jan. 8, 2014 /PRNewswire-USNewswire/ -- James M. Golubieski, president of New Jersey Health Foundation (NJHF) and Foundation Venture Capital Group (FVCG), discussed how these organizations promote the commercialization of research in New Jersey as he addressed a panel at the Research Efficiency Conference in Washington, DC, sponsored by the Association of Academic Health Centers.

At a session "Looking Beyond the NIH" that explored alternate funding sources, Mr. Golubieski discussed the unique model of New Jersey Health Foundation and Foundation Venture Capital Group and how they are helping scientists and universities to keep pace with a quickly moving research environment that has begun to emphasize commercialization as a means of advancing research.

"The fact that we are independent not-for-profit organizations allows us to invest in research at an early stage, providing start-up companies with the financial and strategic support they need to move their research to the next level," Mr. Golubieski explained to the group. 

New Jersey Health Foundation (www.njhf.org) is an independent organization supporting academic research and education programs at universities in New Jersey.  An investment of $10 million to fund its affiliate, Foundation Venture Capital Group (www.foundationventure.com), has allowed FVCG to invest in 10 start up companies with investments of up to $500,000 each.   One company was sold within 18 months at a substantial return on investment.  FVCG is currently selecting 10 more companies for investment.   

The Association of Academic Health Centers (www.aahcdc.org) is a non-profit organization that seeks to advance the nation's health and well-being through vigorous leadership of the nation's academic health centers.

"As economic pressures on research have intensified, the investments by funders like the New Jersey Health Foundation and Foundation Venture Capital Group add important viability to the overall research enterprise," said Dr. Steven A. Wartman, AAHC president and CEO.

In addition to Foundation Venture Capital Group, NJHF operates two other programs to support research in New Jersey.  Its Research Awards Program has granted more than $54 million to researchers in early stages of work since inception of the program.  A new program, Innovation Stage Funding Program, has awarded grants to researchers with promising ideas that may lead to developing patents or intellectual property.

About New Jersey Health Foundation
New Jersey Health Foundation (www.njhf.org) is a not-for-profit corporation that supports biomedical research and health-related education programs in New Jersey through its matching program, its Grants Program and its affiliate, Foundation Venture Capital Group (www.foundationventure.com) which makes private equity investments in life science start- up companies headed toward commercialization in New Jersey.


'/>"/>
SOURCE New Jersey Health Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Custom Metal Fabricators of Stainless Steel Tanks and Components to Attend ISPE New Jersey Chapter 2013 Supplier Showcase and Tabletop Show
2. JTB Law Group, LLC Featured in New Jersey Legal Leaders, Top Rated Lawyers for 2013
3. Renowned New Jersey Plastic Surgeon Dr. Fred Coville Receives Prestigious Speaking Honor
4. Visiting Nurse Association of Northern New Jersey Announces Gardening Program at Friendship House Adult Day Care
5. Black Data Processing Associates (BDPA) New Jersey Hosts 10th Annual Families in Technology Day June 8, 2013
6. Reproductive Medicine Associates of New Jersey Receives ACOG Prize for Paper on SET and CCS, a Pioneering IVF Process
7. Choose New Jersey and Partners to Promote New Jersey As Global Life Science Hub at Worlds Largest Biotechnology Event
8. Masy Systems Increases Validation Personnel in Pennsylvania and New Jersey
9. IntelliCell BioSciences Announces Research Agreement with the New Jersey Center for Biomaterials at Rutgers-The State University of New Jersey
10. New Egg Donation Program, "Ovatures," Launched By Reproductive Medicine Associates Of New Jersey
11. Allergan Opens New Research and Development Center in Bridgewater, New Jersey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... 2016 , ... Proove Biosciences, Inc ., the commercial ... of the Proove Health Foundation . The Foundation is a non-profit organization ... of personalized medicine for tackling the nation’s most-pressing healthcare epidemics. As part of ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... necessary fundamentals to transform technology into a viable company, CereScan’s CEO, John Kelley, ... Mr. Kelley, a recognized leader and mentor in the Denver area business community, ...
(Date:4/29/2016)... Elekta is pleased to announce ... industry-leading treatment planning software, is available for clinical release. ... version 5.11 provides significant performance speed enhancements over ... to four times faster than in previous versions of ... standard Monte Carlo algorithm, users ...
(Date:4/28/2016)... ... April 28, 2016 , ... Connecticut Innovations ... growing companies, today announced the launch of VentureClash , a $5 million ... , “VentureClash looks to attract the best early-stage companies here in Connecticut, ...
Breaking Biology Technology:
(Date:3/9/2016)... March 9, 2016  Crossmatch ® , a ... solutions, today announced the addition of smart features ... multi-factor authentication platform. New contextual and application-specific ... step-up security where it,s needed most — while ... DC . --> Washington, ...
(Date:3/3/2016)... -- FlexTech, a SEMI Strategic Association Partner, awarded five FLEXI ... Leadership in Education, and, in a category new this ... year of the FLEXI Awards and the winners join ... past years . Judging was done on a set ... by a panel of non-affiliated, independent, industry experts. ...
(Date:3/3/2016)... DE SOTO, Kansas , March 3, 2016 /PRNewswire/ ... offer Oncimmune,s Early CDT®-Lung, a blood test to ... lung cancer Early CDT®-Lung test to its ... --> Early CDT®-Lung test to its clients which ... Oncimmune, a leader in early cancer detection, today announced ...
Breaking Biology News(10 mins):